Natixis Advisors, L.P.
- SEC CIK
- 0001018331
- Latest filing
- Aug 14, 2026
ANIP holding history
Ani Pharmaceuticals Inc in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANIP overviewAll 13F holders of ANIPFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −15,807−100.0% | Sold out | Holders |
| Q3 2025 | 15,807 | $1.45M | <0.1% | −3,095−16.4% | Reduced | Holders |
| Q2 2025 | 18,902 | $1.23M | <0.1% | +166+0.9% | Added | Holders |
| Q1 2025 | 18,736 | $1.25M | <0.1% | +135+0.7% | Added | Holders |
| Q4 2024 | 18,601 | $1.03M | <0.1% | +417+2.3% | Added | Holders |
| Q3 2024 | 18,184 | $1.08M | <0.1% | +6,545+56.2% | Added | Holders |
| Q2 2024 | 11,639 | $741.0K | <0.1% | +11,639 | New | Holders |